Azeria Therapeutics, a newly formed drug discovery company, today announced the appointment of Dr Julian Blagg as VP Drug Discovery. Dr Blagg has over 30 years’ experience in medicinal chemistry and drug discovery; he was most recently Deputy Director and Head of Chemistry at The CRUK Cancer Therapeutics Unit at the Institute of Cancer Research.
This author has yet to write their bio.Meanwhile lets just say that we are proud raslade contributed a whooping 2 entries.
Entries by raslade
Azeria Therapeutics Limited, a newly formed drug discovery company, today announced that it has successfully raised £4 million in Series A fundraising from the £70 million CRT Pioneer Fund, managed by Sixth Element Capital LLP (6EC), a UK based fund manager.
CRUK Cambridge Institute
+44 (0)1223 769779